Orexa Commences Phase 2 Trial in Post-Operative Patients with First Patient Dosed – Drugs.com MedNews Orexa Pharmaceuticals, a leading biopharmaceutical...
Aulos Bioscience, a leading biotechnology company, has recently announced the administration of the first dose to a patient in the...
Aulos Bioscience, a leading biotechnology company, has recently announced the administration of the first dose to a patient in the...
The Food and Drug Administration (FDA) has recently granted Fast Track designation to Kyverna Therapeutics’ experimental drug, KYV-101, for the...
Allakos, a biotechnology company focused on developing innovative therapies for allergic and inflammatory diseases, recently announced a significant workforce reduction...
Weekly Updates: Latest News on Vertex & CRISPR Therapeutics, Passing of Arnold Caplan, and Advancements in MS Genetics In the...
Weekly News: Updates on Vertex & CRISPR Therapeutics, the Passing of Arnold Caplan, and Advancements in MS Genetics In the...
A Comprehensive Guide to FC 24 Skill Moves Training Evolutions Skill moves are an essential aspect of football that can...
Unconventional Drug Manufacturer Secures Over $100M Funding for Innovative PTSD Therapy Utilizing Ecstasy Post-Traumatic Stress Disorder (PTSD) affects millions of...
Anavex’s Cash Reserves Remain as Sole Asset Following Multiple Study Failures of Promising Drug Anavex Life Sciences, a biopharmaceutical company...
DA-1726 IND Application Submitted to FDA for Phase 1 Clinical Trial in Obesity Treatment Obesity has become a global epidemic,...
Title: Amgen Provides Regulatory Update on Lumakras® Status in Medical Device News Magazine Introduction Amgen, a leading biotechnology company, has...
BrainStorm Cell Therapeutics, a leading biotechnology company, has recently been granted patents for its allogeneic exosome platform-product in the treatment...
Sarepta Therapeutics, a leading biotechnology company focused on developing innovative gene therapies, is making significant strides in its efforts to...
Sanofi, one of the world’s leading pharmaceutical companies, recently announced the discontinuation of the development of tusamitamab ravtansine, a potential...
